- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00860288
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
December 17, 2020 updated by: Novartis Pharmaceuticals
This is a 2-3 period parallel group study with an adaptive element in Type 2 diabetes patients receiving vildagliptin as add-on therapy to metformin
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1988
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Buenos Aires, Argentina, B1642DCD
- Grupo Medico Alem
-
Buenos Aires, Argentina, B1704ETD
- DIM Clinical Privada
-
Buenos Aires, Argentina, B1824KAJ
- Clinica Medica Sin Internacion
-
Buenos Aires,, Argentina, C1027AAP
- Fundación de Estudios Farmacológicos y de Medicamentos
-
-
Santa Fe
-
Buenos Aires, Santa Fe, Argentina, 3000FNF
- Instituto de Investigaciones Biomedicas
-
Rosario, Santa Fe, Argentina, S2002OJP
- Grupo Colaborative Rosario
-
-
-
-
-
Graz, Austria, 8036
- Universitaetsklinik Graz medizinische Universitaetsklinik;
-
Salzburg, Austria, 5020
- LKH Salzburg Landesklinik fuer Innere Medizin I
-
Wien, Austria, 1060
- Millergasse 7
-
Wien, Austria, 1140
- Hanusch Krankenhaus 1. Med. Abteilung und Nephrodepartment
-
Wiener Neustadt, Austria, 2700
- Kindlergasse 4
-
Wiener Neustadt, Austria
- Kindlergasse 4
-
-
-
-
-
De Pinte, Belgium, 9840
- Private Practice Cardiology (Dr. Hollanders)
-
Genk, Belgium, 3600
- Private Practice (Vernijns)
-
Gozee, Belgium, 6534
- Private Practice (Dr. De Meulemeester)
-
Hasselt, Belgium, 3500
- Huisartsenpraktijk Hygeia
-
Oostham, Belgium, 3945
- Private Practice (Dr. Jaak Mortelmans)
-
-
Sint-Niklaasstraat 117
-
Sint-Gillis-Waas, Sint-Niklaasstraat 117, Belgium, 9170
- Private Practice Diabetology (Dr. Coucke)
-
-
-
-
-
Helsinki, Finland, 2 A 2 00270
- Lihavuustutkimusyksikkö
-
Helsinki, Finland, 47 A 00260
- Mehiläinen Töölö Diabetesklinikka
-
Kuopio, Finland, 70100
- Terveystalo Kuopio
-
Lahti, Finland, 6 C 15110
- Mehiläinen Lahti
-
Oulu, Finland, 90100
- ODL Terveys Oy, Tutkimusyksikkö,
-
Riihimäki, Finland, 11130
- Mehiläinen Riihimäki
-
Tampere, Finland, 33900
- Terveystalo Tampereen työterveys Kalmar
-
Vantaa, Finland, 01600
- Myyrmäen terveysasema
-
-
-
-
-
Augsburg, Germany, 86150
- Internistische Gemeinschaftspraxis Nagel, Dietlein & Hunstiger
-
Augsburg, Germany, 86150
- Praxis Dr. Med. Kurt Rack
-
Bad Kreuznach, Germany, 55545
- Gemeinschaftspraxis S. Maxeiner/Dr. Behr/S. Rupprecht
-
Berlin, Germany, 10117
- Klinische Forschung Berlin-Buch
-
Berlin, Germany, 12247
- Praxis Dr. Med. Ulrike Venschott-Jordan
-
Berlin, Germany, 12347
- Praxis Dr. Med. Monika Kiper
-
Berlin, Germany, 13189
- Praxis Dr. Med. Christina Bondke
-
Bibertal, Germany, 89346
- Bibertal Klinik
-
Diez, Germany, 65582
- Gemeinschaftspraxis Dr. med. Ali Boustani
-
Dorsten, Germany, 46282
- Facharzt fuer Allgemeinmedizin
-
Einbeck, Germany, 37574
- Praxis Dr. Med. Anwar Ansari
-
Essen, Germany, 45130
- Hausaerzte am Stern Dr. Med. Blume / Dr. Med. Garanin
-
Essen, Germany, 45144
- Praxis Dr. Med. Roland Kutzke
-
Essen, Germany, 45276
- Praxis Dr. Med. Thorsten Rau
-
Falkensee, Germany, 14612
- Praxis Dr. Med. Joerg Luedemann / Facharzt fuer Innere Medizin - Diabetologie
-
Frankfurt, Germany, 60599
- Praxis Dr. Med. Daniela Freise
-
Freital, Germany, 01705
- Dial.-Med. Kerstin Steinbach
-
Fulda, Germany, 36037
- Gemeinschaftspraxis
-
Grimma, Germany, 04668
- Praxis Dr. Med. Wolfgang Krause
-
Hagenow, Germany, 19230
- Krankenhaus Hagenow, Innere Medizin
-
Hamburg, Germany, 20097
- MVZ-medicum Hamburg
-
Hamburg, Germany, 22041
- Diabetes-Zentrum Wandsbek
-
Herne, Germany, 44653
- Gemeinschaftspraxis Dr. Grüneberg, Dr.Mehring, Bitterer-Tölle
-
Hildesheim, Germany, 31139
- Praxis Dr. Med. Helmut Anderten
-
Kahla, Germany, 07768
- Praxis Dr. Med. Juergen Landschulze
-
Karlsruhe, Germany, 76199
- Praxis Dr. Med. Julia Chevts
-
Kassel, Germany, 34125
- Praxis Dr. Med. Hans-Helmut Seibert
-
Koeln, Germany, 50823
- Praxis Dr. Med. Claudia Ulbrich
-
Kuenzing, Germany, 94550
- Dres. Klein/Minnich
-
Leipzig, Germany
- Praxis Dr. Med. Birgit Hoene
-
Luebeck, Germany, 23562
- Pro Scientia med
-
Meissen, Germany, 01662
- Diabetes Schwerpunktpraxis
-
Muehldorf, Germany, 84453
- Praxis Dres. Prohaska / Lindner
-
Muenchen, Germany, 81373
- Praxis Dr. Med. Claus-Michael Grimm
-
Muenster, Germany, 48153
- Praxis Dr. Fischer & Dr. Keuthage
-
Neumunster, Germany, 24534
- Gemeinschaftspraxis Dr. Uwe Böckmann/Dr. med. Maren Molkewehrum
-
Oberhausen, Germany, 46049
- Praxis Dr. Med. Joachim Etter
-
Potsdam, Germany, 14469
- IkFE Studiencenter Potsdam GMBH i.G.
-
Quakenbrueck, Germany, 49610
- Diabetes Center Quakenbrueck
-
Reinfeld, Germany, 23858
- Praxis Dr. Altwicker, Dr. Kanis
-
Rothenburg, Germany
- Praxis Dr. Med. Ulrich Aigner
-
Schoenberg, Germany, 23923
- Praxis Dr. Med. Sabine Sedl
-
Schrobenhausen, Germany, 86529
- Dres. Hiltensperger & Schaal
-
Schwabenheim, Germany, 55270
- Praxis Hans-Joachim Herrmann/Dr. med. B. Bauer
-
Stuttgart, Germany, 70469
- Praxis Dr. Med. Ottmar Herfert
-
Veitsbronn, Germany, 90587
- Praxis Dr. Med. Doru Popa
-
Viernheim, Germany, 68519
- Gemeinschaftspraxis Gerhard Steinmaier und Dr. Med. Werner Bauer
-
Wangen, Germany, 88239
- Gemeinschaftspraxis Sauter
-
Weissenhorn, Germany, 89264
- Praxis Dr. Med. Rudolf Matthias Remppis
-
Welzheim, Germany, 73642
- Praxis Dr. Med. Peter Genthner
-
Wetzlar, Germany, 35584
- Gemeinschaftspraxis Dr. med. Reinhold Schneider und Christine Schneider
-
-
-
-
-
Athens, Greece, GR11527
- Laiko General Hospital,
-
Larisa, Greece, GR 35100
- Lamia General Hospital
-
Thessaloniki, Greece, GR56403
- Papageorgiou General Hospital
-
-
-
-
-
Guatemala City, Guatemala, 01001
- Clínica y Hospital Colón del Paciente Diabético
-
Guatemala City, Guatemala, 01010
- Endonutri S.A
-
Guatemala City, Guatemala, 11-49
- Clínica y Hospital Colón del Paciente Diabético
-
Guatemala City, Guatemala, Oficina 1114
- Clinica Dr. Erick Turcios
-
Guatemala City, Guatemala, Oficina 909
- Endonutri S. A.
-
Guatemala City, Guatemala
- Clinica Dr. Sergio Bran
-
-
-
-
-
Budapest, Hungary, 1032
- Szent Margit Hospita
-
Budapest, Hungary, 1041
- Károlyi Sándor Hospital
-
Budapest, Hungary, 1115
- Szent Imre Hospital
-
Csongrád, Hungary, 6640
- Konszenzusplusz Kft.
-
Győr, Hungary, 9023
- Petz Aladar Hospital
-
Nyíregyháza, Hungary
- Josa Andras Hospital
-
Szeged, Hungary, 6720
- Szte-Áok I
-
Szekszárd, Hungary, 7100
- Balassa Janos Hospital
-
Zalaegerszeg, Hungary, 8900
- Zala Megyei Hospital
-
-
-
-
-
Chennai, India, 13
- M. V. Hosp for Diabetes P. Ltd. 4,
-
Hyderabaad, India, 500 036
- Medicity Hospital
-
Hyderabaad, India, 500 082
- Nizam's Institute of Medical Sciences,
-
Jaipur, India, 302001
- S. R. Kalla Memorial gastro and general hosp,
-
Vellore, India, P. O. Box. No. 3.
- Christian Medical College,
-
-
Karantaka
-
Bangalore, Karantaka, India, 560 017
- Manipal Hospital,
-
-
Kerela
-
Trivandrum, Kerela, India, 695 001
- Health and Research Centre
-
-
Madhya Pradesh
-
Indore, Madhya Pradesh, India, 452001
- Diabetes Thyroid Hormone Research Institute Pvt Ltd.
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 500 082
- Madras Diabetes Research Foundation
-
-
-
-
-
Rishon Le Zion, Israel, 75650
- Maccabi Healthcare Services
-
Safed, Israel, 13100
- ZIV Medical Center
-
-
-
-
-
Arenzano, Italy
- U.O.C. di Diabetologia e Malattie Metaboliche
-
Bergamo, Italy
- U.S.C. di Endocrinologia (Ingresso 13 - piano 2) Dip. di Medicina
-
Campobasso, Italy
- U.O.C. Diabetologia Endocrinologia Dip. Medico
-
Casorate Primo, Italy
- U.O. Medicina Generale
-
Catania, Italy
- I Divisione Medicina
-
Chieri, Italy
- U.O. Malattie Metaboliche e Diabetologia
-
Cosenza, Italy
- U.O.C. di Medicina d'Urgenza e Pronto Soccorso
-
Firenze, Italy
- Servizio Diabetologia, SOD Cardiologia Geriatrica - D.A.I. del Cuore e dei Vasi
-
Mercato San Severino, Italy
- Centro Diabetologico Malattie Metaboliche
-
Milano, Italy
- Divisione Malattie Metaboliche e Diabetologia
-
Milano, Italy
- S. Semplice Dip. di Endocrinologia e Diabetologia Dip. di Medicina Interna
-
Milano, Italy
- U.O. Medicina II - Dip. Medicina Interna
-
Milano, Italy
- Unità Cardio-Metabolica e Trials Clinici Dipartimento di Medicina Interna
-
Olbia, Italy
- U.O. Diabetologia
-
Roma, Italy
- Centro per l'Aterosclerosi Dip. di Medicina Interna
-
Roma, Italy
- U.O. Endocrinologia e Diabetologia
-
Roma, Italy
- U.O.C. di Diabetologia c/o AUSL ROMA B - Sede Territoriale
-
Roma, Italy
- U.O.C. di Medicina Interna B - BMI02 Dip. Scienze Cliniche - II Clinica Medica
-
Siena, Italy
- S. S. di Diabetologia Dip. Med. Interna e Malattie Metaboliche
-
Vibo Valentia, Italy
- S.C. Prevenzione-Riabilitazione Cardiologica presso ex-Dispensario
-
-
-
-
-
Seoul, Korea, Republic of
- Eulji General Hospital
-
Seoul, Korea, Republic of
- Kangbuk Samsung Medical Center
-
Seoul, Korea, Republic of
- Korea University Guro Hospital
-
Seoul, Korea, Republic of
- The Catholic University of Korea Holy Family Hospital
-
Suwon, Korea, Republic of
- Ajou University Hospital
-
-
-
-
-
Daugavpils, Latvia, 5417
- Daugavpils Regional Hospital
-
Liepaja, Latvia, 3401
- Primary Health Centre of Jaunliepaja
-
Ogre, Latvia, 5001
- Private practice of endocrinology
-
Riga, Latvia, 1002
- Center of Endocrinology
-
Riga, Latvia, 1057
- Riga Outpatient Clinic "Dziednieciba"
-
Talsi, Latvia, 3201
- Talsi Clinical Hospital
-
Valmiera, Latvia, 4201
- Endocrinology Department of Vidzemes Hospital
-
-
-
-
-
Alytus, Lithuania, 63257
- JSC "Klinikiniai sprendimai"
-
Kaunas, Lithuania, 50009
- Kaunas Medical University Hospital
-
Kaunas, Lithuania, 45130
- Kaunas District Hospital
-
Kaunas, Lithuania, 48259
- Kaunas Silainiai Outpatient Clinic
-
Kaunas, Lithuania, 51270
- Kaunas Dainavos Outpatient Clinic
-
Vilnius, Lithuania, 08661
- Vilnius University Hospital Santariskiu Clinics
-
Vilnius, Lithuania, 09112
- Private Endocrinology Clinic
-
-
-
-
-
Durango, Mexico, 34070
- Clínica de Diabetes de la Secretaria de Salud de Durango
-
Mexico City, Mexico, 06700
- ARKE Estudios Clínicos S.A. de C.V.
-
-
Durango
-
Mexico City, Durango, Mexico, 03300
- Comité Bioetico para la Investigación Clínica S.C.
-
-
Morelos.
-
Cuernavaca, Morelos., Mexico
- Unidad Metabolica y Cardiovascular S.C.
-
-
Polanco Chapultepec
-
Mexico City, Polanco Chapultepec, Mexico, 11550
- Clínica Eugenio Sue
-
-
-
-
-
Hønefoss, Norway, 3503
- Flattum legesenter
-
Kristiansand, Norway
- Randesund Helsesenter
-
Oslo, Norway
- Oslo Universitetssykehus
-
Oslo, Norway, 0580
- Sinsenklinikken
-
Stavanger, Norway, 4020
- Hinnastrekanten legekontor
-
Vennesla, Norway
- Vennesla legesenter
-
-
-
-
-
Arequipa, Peru
- Clinica San Miguel
-
LIma, Peru
- Clinica San Borja
-
Lima, Peru
- Hospital Nacional Guillermo Almenara Irigoyen
-
Lima, Peru
- Hospital Nacional Cayetano Heredia
-
Lima, Peru
- Clinica Geriatrica Militar
-
Lima, Peru
- Clinica Senor de los Milagros
-
-
-
-
-
Bydgoszcz, Poland, 85 822
- Bydgoskie Centrum Diabetologii i Endokrynologii
-
Kutno, Poland, 99 300
- NZOZ "Specjalista" Sp z o. o.
-
Mielec, Poland, 39 300
- Oddzial Chorob Wewnetrznych
-
Poznan, Poland, 60 521
- Poradnia Lekarza Rodzinnego
-
Poznań, Poland, 60 773
- Poznański Ośrodek Medyczny "NOVAMED"
-
-
-
-
-
Baia Mare, Romania, ap. 72
- CMI Cardiologie "Dr. Pop Calin Florin"
-
Bucharest, Romania, district 1
- "C. I. Parhon" Endocrinology Institute
-
Bucharest, Romania, district 2
- Medical Centre "Sanatatea Ta" SRL
-
Oradea, Romania, ap. 3
- Medical Practice SRL
-
Oradea, Romania, ap. 5
- Anamed SRL
-
Ploiesti, Romania, no. 100
- Emergency County Hospital Ploiesti
-
Timisoara, Romania, no. 27
- Policlinica "Dr. Citu"
-
-
-
-
-
Bratislava, Slovakia, 821 07
- Diametabol.s.r.o.,
-
Povazska Bystrica, Slovakia, 017 01
- MUDr. Margita Kiripolska s.r.o
-
-
Slovak Republic
-
Bratislava, Slovak Republic, Slovakia, 811 02
- MEDISPEKTRUM s.r.o,
-
Presov, Slovak Republic, Slovakia, 081 81
- .Interna klinika, FN J.A. Reimana
-
-
Slovakia Republic
-
Bratislava, Slovakia Republic, Slovakia, 81272
- Diabetologicka ambulancia,
-
Kosice, Slovakia Republic, Slovakia, 040 01
- Diabetologicka ambulancia
-
Lucenec, Slovakia Republic, Slovakia, 984 01
- Diabetologicka ambulancia,
-
Nove Zamky, Slovakia Republic, Slovakia, 940 01
- NZZ Diabetologicka ambulancia
-
Trencin, Slovakia Republic, Slovakia, 911 01
- Diabetes Centrum s.r.o
-
Zilina, Slovakia Republic, Slovakia, 010 01
- Diabetologicka ambulancia,
-
-
-
-
-
Caracas, Venezuela
- Hospital Dr Miguel Perez Carreño. Servicio de Endocrinología. Sotano.
-
Caracas., Venezuela, Piso 4. Urb.
- Hospital Militar Dr Carlos Arvelo. Final Av. José Angel Lamas. Servicio de Endocrinología.
-
-
Carabobo.
-
Valencia, Carabobo., Venezuela
- Ambulatorio Militar Tipo III Paramacay. Avenida Universidad. Sector Santa Ana. Naguanagua.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 78 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients 18-78 years old inclusive at Visit 1
- T2DM patients treated with metformin for at least 3 months and a stable dose of at least 1500 mg daily for a minimum of 4 weeks prior to Visit 1
- Patient agreement to maintain same dose of metformin throughout study
- HbA1c of ≥ 7.0 and ≤ 9.5 % at Visit 1
- Body Mass Index (BMI) in the range of 22-45 kg/m2 at visit 1
Exclusion Criteria:
- Pregnant or nursing (lactating) women
- FPG ≥ 270 mg/dL ( ≥ 15.0 mmol/L)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Placebo
|
|
ACTIVE_COMPARATOR: Sitagliptin
|
|
EXPERIMENTAL: Vildagliptin Dose 1
|
|
EXPERIMENTAL: Vildagliptin Dose 2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the efficacy of vildagliptin as add-on therapy to metformin in patients with T2DM by assessing changes in HbA1c with vildagliptin added to metformin to that of placebo added to metformin after 24 weeks of treatment
Time Frame: 24 weeks
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the efficacy of vildagliptin as add-on therapy to metformin in patients with T2DM by assessing changes in HbA1c with vildagliptin added to metformin to that of sitagliptin added to metformin after 24 weeks of treatment.
Time Frame: 24 weeks
|
24 weeks
|
To evaluate the efficacy of vildagliptin as add-on therapy to metformin in patients with T2DM by assessing changes in fasting plasma glucose with vildagliptin added to metformin to that of placebo added to metformin after 24 weeks of treatment.
Time Frame: 24 weeks
|
24 weeks
|
To evaluate the efficacy of vildagliptin as add-on therapy to metformin in patients with T2DM by assessing changes in fasting plasma glucose with vildagliptin added to metformin to that of sitagliptin added to metformin.
Time Frame: 24 weeks
|
24 weeks
|
To evaluate the safety and tolerability of vildagliptin compared to placebo and sitagliptin over 24 weeks of treatment as add-on therapy to metformin in patients with T2DM.
Time Frame: 24 weeks
|
24 weeks
|
To evaluate the long-term safety and tolerability of vildagliptin compared to sitagliptin over the entire study duration as add-on therapy to metformin in patients with T2DM.
Time Frame: 76 weeks
|
76 weeks
|
To evaluate the body weight change from baseline with vildagliptin compared to placebo and sitagliptin after 24 weeks of treatment as add-on therapy to metformin in patients with T2DM.
Time Frame: 24 weeks
|
24 weeks
|
To evaluate the long-term efficacy of vildagliptin compared to sitagliptin over the entire study duration as add-on therapy to metformin in patients with T2DM.
Time Frame: 76 weeks
|
76 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (ACTUAL)
March 1, 2011
Study Completion (ACTUAL)
March 1, 2011
Study Registration Dates
First Submitted
March 10, 2009
First Submitted That Met QC Criteria
March 11, 2009
First Posted (ESTIMATE)
March 12, 2009
Study Record Updates
Last Update Posted (ACTUAL)
December 29, 2020
Last Update Submitted That Met QC Criteria
December 17, 2020
Last Verified
January 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Diseases
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Protease Inhibitors
- Incretins
- Dipeptidyl-Peptidase IV Inhibitors
- Metformin
- Sitagliptin Phosphate
- Vildagliptin
Other Study ID Numbers
- CLAF237B2224
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States